Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

They are doing it not primarily for weight loss — the effect that has made Ozempic a Hollywood staple and a reliable awards-show punchline — but for the surprising and widely touted side ...

Similarly, Zepbound is Mounjaro's weight-loss counterpart ... Older GLP-1 medications like Victoza, Trulicity and even Ozempic possess one underlying mechanism. As "GLP-1 receptor agonists ...

Is there really a drug that makes you lose weight effortlessly? Enter Ozempic, the buzz-worthy medication everyone’s talking about. Originally intended to manage type 2 diabetes, it has now ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

A KKF poll finds that, overall, 12% of Americans have used or are using a GLP-1 agonist like Trulicity, Ozempic or Mounjaro for weight loss or to manage Type 2 diabetes and associated complications.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...